Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Heparin-Rivaroxaban'
Heparin-Rivaroxaban published presentations and documents on DocSlides.
Thromboembolic protocols
by cecilia
& safe anticoagulant prescribing. July 2020. D...
Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:
by giovanna-bartolotta
Rivaroxaban Plus Aspirin in Patients With and Wit...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...
Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing
by roberts
The BRIGHT-4 Trial. Gregg W. Stone MD. On behalf o...
Efficacy and Safety of Low Molecular Weight Heparin compared to Unfractionated Heparin for Chronic
by mitsue-stanley
R. eview and Meta-Analysis.. Dinesh Keerty, MD. T...
HEPARIN INDUCED THROMBOCYTOPENIA
by ellena-manuel
(HIT). HEPARIN-INDUCED THROMBOCYTOPENIA. Unfracti...
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
by HoneyBun
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
A ssessment of D ual antiplatelet therapy versus
by coursion
R. ivaroxaban . I. n atrial . F. ibrillation patie...
Ima A. Kusuma , MD, FIHA
by hirook
“JIH. ” Hospital, Yogyakarta, Indonesia. The U...
A ssessment of D ual antiplatelet therapy versus
by stefany-barnette
A ssessment of D ual antiplatelet therapy versus...
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
CAD/PAD in Primary Care CV Risk in Stable Outpatients
by stefany-barnette
Stratified by Baseline CV Risk Category. Aspirin ...
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
New Oral Anticoagulant
by mitsue-stanley
R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
Recent ACS: STEMI, NSTEMI, UA
by danika-pritchard
Stabilized 1-7 Days Post-Index Event. Exclusions:...
Depolymerization of heparin benzyl ester in a flow system
by brooke
Richard T. Taylor* and Rebecca G. Brunner. Departm...
Approach to thrombocytopenia
by eleanor
. jithin. P JR1 Medicine. introduction. P. latel...
8: Anticoagulants Introduction about coagulation cascade
by ethlyn
. Classify drugs acting as anticoagulants. . Elab...
Semen Dynamics Dr. Pramod Kumar
by lam
Department of Veterinary Physiology. BVC, Patna. C...
ORAL SURGERY IN PATIENTS ON ANTICOAGULANT THERAPY
by eloise
Presented by-. Dr. Varun Mittal, PG. Dept of Maxil...
SLE with Secondary APLA Complicating Pregnancy
by josephine
Presentor. . Dr. . B.Sreevidya. FNB Resident, Fer...
Diagnosis Thrombocytopenia HITA POCKET GUIDE FOR THE CLINICIAN DECEM
by evelyn
ASH CLINICAL PRACTICE GUIDELINESVENOUS THROMBOEMBO...
Introduction
by elizabeth
This s tandard applies to inpatients aged over 16...
Guidelines for Using Bivalirudin During Cardiopulmonary Bypass Surgery
by brooke
During cardiopulmonary bypass procedures, systemic...
FUTURA/OASIS-8 Major bleeds/minor bleeds/vascular access site complications at 48 hours: 4.7% of th
by Goofball
Death, MI, or revascularization: 4.5% vs. 2.9% (p ...
Venous Thromboembolism (VTE) in pregnancy
by RainbowGlow
Dr Henan Dh Skheel. Department Of . Obs&Gyn. 2...
Anticoagulants Did You Know
by PrincessPeach
?. That . major bleeding . occurs in about . 6.5% ...
Diagnosis & Management
by iris
of Heparin-Induced Thrombocytopenia. An Educationa...
Load More...